(312) 275-5850 9-5pm CST
CART $0.00
Your shopping cart is empty!
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

Metrix-Secure #66410 - 500ml EVA Legless Bag Male Screw Connector, 50/CS

Metrix-Secure #66410 - 500ml EVA Legless Bag  Male Screw Connector, 50/CS
CIA7001208
CASE
Special Order
$295.00

Allow C.I.A. to white-glove your request for this item

Not buying today? Need a volume discount, Net 30 terms, or a government quote? Got a backorder, and need immediate stock? That’s exactly what we do best. Let us solve your problem.

Product Description

Metrix-Secure 66410 - 500ml EVA Legless Bag Male Screw Connector, 50/CS

500 ml Ethyl Vinyl Acetate (EVA) Legless Bag with Male Screw Connector

Ethyl Vinyl Acetate (EVA) bags are constructed from a copolymer, monolayer film.

Our EVA single-use bags are designed for parenteral applications. They are made from high quality, Class VI film that

  • EVA container.
  • Non-DEHP bag, ports and tubing.
  • Latex free.
  • Fill leg with male screw connector and female threads.
  • Offers complete flexibility by providing the fill legs separately.
  • Fill legs are available for most TPN compounding and gravity filling applications.

These bags are specifically designed to provide strong seals, extraordinary robustness, superior flex, crack and pin-hole resistance

  • All EVA Legless Bags have an attached non-reopening clamp.

Storing

EVA must be stored at temperature under 40 degree celsius. The sun radiation, excessive heat, or humidity is prohibited.

DEHP Free

Infusion Therapy Standards of Practice advise to use administration sets not made with di-ethylhexyl-phthalate (DEHP) to administer lipid-based infusates, such as IVFE or TNA. DEHP is lipophilic and is extracted into the lipid solution with commonly used polyvinyl chloride administration sets and containers. DEHP is considered a toxin, and studies have demonstrated increased DEHP levels in lipid solutions, which is especially a risk with neonatal, pediatric, and long-term home care patients (42).